Occult hepatitis B virus infection in immunocompromised patients

Braz J Infect Dis. 2008 Aug;12(4):300-5. doi: 10.1590/s1413-86702008000400008.

Abstract

Occult hepatitis B infection is characterized by hepatitis B virus (HBV) DNA in the serum in the absence of hepatitis B surface antigen (HBsAg). We assessed occult HBV infection prevalence in two groups of immunocompromised patients (maintenance hemodialysis patients and HIV-positive patients) presenting HBsAg-negative and anti-HBc positive serological patterns, co-infected or not by HCV. Thirty-four hemodialysis anti-HIV negative patients, 159 HIV-positive patients and 150 blood donors who were anti-HBc positive (control group) were selected. HBV-DNA was detected by nested-PCR. Occult hepatitis B infection was not observed in the hemodialysis patients group but was found in 5% of the HIV-patients and in 4% of the blood donors. Immunosuppression in HIV positive patients was not a determining factor for occult HBV infection. In addition, no significant relationship between HBV-DNA and HCV co-infection in the HIV-positive patient group was found. A lack of significant associations was also observed between positivity for HBV-DNA and CD4 count, viral load and previous lamivudine treatment in these HIV-positive patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • CD4 Lymphocyte Count
  • Case-Control Studies
  • DNA, Viral / blood
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • Hepatitis B / diagnosis*
  • Hepatitis B / immunology
  • Hepatitis B Antibodies / blood
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology
  • Humans
  • Immunocompromised Host / immunology*
  • Lamivudine / immunology
  • Lamivudine / therapeutic use
  • Male
  • Middle Aged
  • Prevalence
  • Renal Dialysis / adverse effects*
  • Viral Load

Substances

  • DNA, Viral
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Lamivudine